Genocea Biosciences (GNCA) Misses Q2 EPS by 2c

Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c